siRNA nanoparticles targeting CaMKIIγ in lesional macrophages improve atherosclerotic plaque stability in mice is a research paper published in Science Translational Medicine (2020). On theSindex it has a DataRank of 0. It has been cited 244 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: HL127464
National Institutes of Health
Grant: HL132412
National Institutes of Health
Grant: HL145228
Brigham and Women’s Hospital
Grant: 122829
NHLBI NIH HHS
Grant: P01 HL087123
NHLBI NIH HHS
Grant: R00 HL145131
NHLBI NIH HHS
Grant: R01 HL127464
NHLBI NIH HHS
Grant: K99 HL145131
NHLBI NIH HHS
Grant: R01 HL132412
NHLBI NIH HHS
Grant: R35 HL145228
National Institutes of Health
Grant: 1K99HL145131-01
Processing of Apoptotic Cell-Derived Cargo by Macrophages Continues Efferocytosis and Drives Atherosclerosis Regression
National Institutes of Health
Grant: 5R01HL127464-04
Enhancing Inflammation Resolution in Atherosclerosis via Targeted Nanoparticle-Mediated Delivery of Biologics
National Institutes of Health
Grant: 5R01HL132412-02
"MerTK Cleavage and Signaling in Atherosclerosis"
FWCI
9.15
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Targeted delivery of MerTK protein via cell membrane engineered nanoparticle enhances efferocytosis and attenuates atherosclerosis in diabetic ApoE−/− Mice
Additional file 1 of Targeted delivery of MerTK protein via cell membrane engineered nanoparticle enhances efferocytosis and attenuates atherosclerosis in diabetic ApoE−/− Mice